Cargando…

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor

Deregulation of the cyclin‐dependent kinases (CDKs) has been implicated in the pathogenesis of multiple cancer types. Consequently, CDKs have garnered intense interest as therapeutic targets for the treatment of cancer. We describe herein the molecular and cellular effects of CCT068127, a novel inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whittaker, Steven R., Barlow, Clare, Martin, Mathew P., Mancusi, Caterina, Wagner, Steve, Self, Annette, Barrie, Elaine, Te Poele, Robert, Sharp, Swee, Brown, Nathan, Wilson, Stuart, Jackson, Wayne, Fischer, Peter M., Clarke, Paul A., Walton, Michael I., McDonald, Edward, Blagg, Julian, Noble, Martin, Garrett, Michelle D., Workman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830651/ https://www.ncbi.nlm.nih.gov/pubmed/29063678 http://dx.doi.org/10.1002/1878-0261.12148

Ejemplares similares

A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
por: Dale, Trevor, et al.
Publicado: (2015)

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19
por: Mallinger, Aurélie, et al.
Publicado: (2016)

Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9
por: Rye, Carl S., et al.
Publicado: (2016)

Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression
por: Liu, Wenlou, et al.
Publicado: (2022)

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
por: Wood, Daniel J., et al.
Publicado: (2019)

CDK1 structures reveal conserved and unique features of the essential cell cycle CDK
por: Brown, Nicholas R., et al.
Publicado: (2015)

Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
por: Chen, Mengqian, et al.
Publicado: (2019)

2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19
por: Mallinger, Aurélie, et al.
Publicado: (2016)

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13
por: Yang, Jianzhang, et al.
Publicado: (2022)

Cyclin K goes with Cdk12 and Cdk13
por: Kohoutek, Jiri, et al.
Publicado: (2012)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

CDK1 and CDK2 regulate NICD1 turnover and the periodicity of the segmentation clock
por: Carrieri, Francesca Anna, et al.
Publicado: (2019)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
por: Chessum, Nicola E. A., et al.
Publicado: (2017)

Cdk12 regulates DNA repair genes by suppressing intronic polyadenylation
por: Dubbury, Sara J., et al.
Publicado: (2018)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Regulatory functions of the Mediator kinases CDK8 and CDK19
por: Fant, Charli B., et al.
Publicado: (2018)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

Identification and Characterization of an Irreversible Inhibitor of CDK2
por: Anscombe, Elizabeth, et al.
Publicado: (2015)

The Cdk1/Cdk2 homolog CDKA;1 controls the recombination landscape in Arabidopsis
por: Wijnker, Erik, et al.
Publicado: (2019)

CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
por: Bisteau, Xavier, et al.
Publicado: (2013)

Cdk2 and Cdk4 cooperatively control the expression of Cdc2
por: Berthet, Cyril, et al.
Publicado: (2006)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
por: Dannappel, Marius Volker, et al.
Publicado: (2019)

Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
por: Majumdar, Abir, et al.
Publicado: (2021)

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
por: Pasqua, A. Elisa, et al.
Publicado: (2023)

CDK13 cooperates with CDK12 to control global RNA polymerase II processivity
por: Fan, Zheng, et al.
Publicado: (2020)

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines
por: Coxon, Christopher R., et al.
Publicado: (2016)

Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors.
por: Kovatcheva, Marta, et al.
Publicado: (2017)

Regulation of CDK4
por: Bockstaele, Laurence, et al.
Publicado: (2006)

Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression
por: Lin, Yueh-Te, et al.
Publicado: (2021)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen
por: Cheeseman, Matthew D., et al.
Publicado: (2016)

A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1
por: Pinhero, Reena, et al.
Publicado: (2004)

MEN1-tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2
por: Gillam, Mary P., et al.
Publicado: (2014)

CDK2 Regulates HIV-1 Transcription by Phosphorylation of CDK9 on Serine 90
por: Breuer, Denitra, et al.
Publicado: (2012)

JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
por: Colleoni, B, et al.
Publicado: (2017)

CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium
por: Prieto, Susana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ggnn1uu8d1msh6gt6hout24i66